TY - JOUR
T1 - AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases
T2 - A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD
AU - Gu, Phillip
AU - Mendonca, Oreen
AU - Carter, Dan
AU - Dube, Shishir
AU - Wang, Paul
AU - Huang, Xiuzhen
AU - Li, Debiao
AU - Moore, Jason H.
AU - McGovern, Dermot P.B.
N1 - Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journ
PY - 2024/12/5
Y1 - 2024/12/5
N2 - Endoscopy, histology, and cross-sectional imaging serve as fundamental pillars in the detection, monitoring, and prognostication of inflammatory bowel disease (IBD). However, interpretation of these studies often relies on subjective human judgment, which can lead to delays, intra- and interobserver variability, and potential diagnostic discrepancies. With the rising incidence of IBD globally coupled with the exponential digitization of these data, there is a growing demand for innovative approaches to streamline diagnosis and elevate clinical decision-making. In this context, artificial intelligence (AI) technologies emerge as a timely solution to address the evolving challenges in IBD. Early studies using deep learning and radiomics approaches for endoscopy, histology, and imaging in IBD have demonstrated promising results for using AI to detect, diagnose, characterize, phenotype, and prognosticate IBD. Nonetheless, the available literature has inherent limitations and knowledge gaps that need to be addressed before AI can transition into a mainstream clinical tool for IBD. To better understand the potential value of integrating AI in IBD, we review the available literature to summarize our current understanding and identify gaps in knowledge to inform future investigations.
AB - Endoscopy, histology, and cross-sectional imaging serve as fundamental pillars in the detection, monitoring, and prognostication of inflammatory bowel disease (IBD). However, interpretation of these studies often relies on subjective human judgment, which can lead to delays, intra- and interobserver variability, and potential diagnostic discrepancies. With the rising incidence of IBD globally coupled with the exponential digitization of these data, there is a growing demand for innovative approaches to streamline diagnosis and elevate clinical decision-making. In this context, artificial intelligence (AI) technologies emerge as a timely solution to address the evolving challenges in IBD. Early studies using deep learning and radiomics approaches for endoscopy, histology, and imaging in IBD have demonstrated promising results for using AI to detect, diagnose, characterize, phenotype, and prognosticate IBD. Nonetheless, the available literature has inherent limitations and knowledge gaps that need to be addressed before AI can transition into a mainstream clinical tool for IBD. To better understand the potential value of integrating AI in IBD, we review the available literature to summarize our current understanding and identify gaps in knowledge to inform future investigations.
KW - artificial intelligence
KW - deep learning
KW - endoscopy
KW - histology
KW - inflammatory bowel disease
KW - medical imaging
KW - radiomics
UR - http://www.scopus.com/inward/record.url?scp=85196710458&partnerID=8YFLogxK
U2 - 10.1093/ibd/izae030
DO - 10.1093/ibd/izae030
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 38452040
AN - SCOPUS:85196710458
SN - 1078-0998
VL - 30
SP - 2467
EP - 2485
JO - Inflammatory Bowel Diseases
JF - Inflammatory Bowel Diseases
IS - 12
ER -